RELX Plc
Research RELX Plc (RELX) on Bullrun: market cap USD 63.64B, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRELX
- ExchangeNYSE
- CountryUnited Kingdom
- SectorIndustrials
- IndustrySpecialty Business Services
- CurrencyUSD
- Market capUSD 63.64B
- Dividend yield2.6%
- Financial periodQ2 2026
Valuation Snapshot
latest market cap is USD 63.64B; dividend yield is 2.6%.
Peer valuation comparison
Latest dividend yield is 2.58% versus a Industrials sector median of 2.39% (7.9% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 63.64B | n/a | 2.6% | 0.94 |
| 2025 | 2025-12-31 | USD 73.53B | n/a | 2.0% | 0.82 |
| 2024 | 2024-12-31 | USD 84.30B | n/a | 1.7% | 0.76 |
| 2023 | 2023-12-29 | USD 74.62B | n/a | 1.7% | 0.69 |
| 2022 | 2022-12-30 | USD 52.93B | n/a | 2.4% | 0.67 |
| 2021 | 2021-12-31 | USD 62.92B | n/a | 2.1% | 0.67 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.94 USD, yield 2.6%.
About RELX Plc
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions.
Related stock research
Other Industrials stocks
Frequently asked questions
What is RELX Plc's market cap?
RELX Plc's market capitalization is USD 63.64B.
Does RELX Plc pay a dividend?
RELX Plc has a dividend yield of 2.6%.
What does RELX Plc do?
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products.